Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer

Author: Welch Stephen A   Moore Malcolm J  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.3, Iss.3, 2007-06, pp. : 247-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract